ADMA - CIK 0001368514
ADMA BIOLOGICS, INC. has filed 988 documents with the SEC between 2006 and 2026. The most frequent type is insider trade (326 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Company correspondence | CORRESP | 2025-08-13 | - |
| SCHEDULE 13G | - | 2025-08-11 | - |
| Quarterly report | 10-Q | 2025-08-06 | 2025-06-30 |
| Major company event | 8-K | 2025-08-06 | 2025-08-05 |
| Insider trade | 4 | 2025-08-01 | 2025-07-30 |
| SEC correspondence | UPLOAD | 2025-07-30 | - |
| SCHEDULE 13G/A | - | 2025-07-29 | - |
| Insider trade | 4 | 2025-07-28 | 2025-07-24 |
| Insider trade | 4 | 2025-07-28 | 2025-07-24 |
| Company correspondence | CORRESP | 2025-07-23 | - |
| Insider trade | 4 | 2025-07-16 | 2025-07-15 |
| SEC correspondence | UPLOAD | 2025-07-16 | - |
| Insider sale notice | 144 | 2025-07-15 | - |
| Insider trade | 4 | 2025-06-30 | 2025-06-26 |
| Insider trade | 4 | 2025-06-18 | 2025-06-16 |
| Insider trade | 4 | 2025-06-16 | 2025-06-12 |
| Insider sale notice | 144 | 2025-06-12 | - |
| Insider trade | 4 | 2025-06-11 | 2025-06-09 |
| Insider trade | 4 | 2025-06-10 | 2025-06-09 |
| Insider sale notice | 144 | 2025-06-09 | - |
| Insider sale notice | 144 | 2025-06-04 | - |
| Major company event | 8-K | 2025-06-04 | 2025-06-04 |
| Insider trade | 4 | 2025-05-23 | 2025-05-21 |
| Insider sale notice | 144 | 2025-05-21 | - |
| Insider trade | 4 | 2025-05-16 | 2025-05-15 |
| SCHEDULE 13G | - | 2025-05-13 | - |
| SCHEDULE 13G | - | 2025-05-09 | - |
| Quarterly report | 10-Q | 2025-05-07 | 2025-03-31 |
| Major company event | 8-K | 2025-05-07 | 2025-05-05 |
| SCHEDULE 13G/A | - | 2025-04-30 | - |
| Major company event | 8-K | 2025-04-28 | 2025-04-28 |
| Insider trade | 4 | 2025-04-16 | 2025-04-15 |
| Annual report to shareholders | ARS | 2025-04-15 | 2024-12-31 |
| Proxy materials | DEFA14A | 2025-04-15 | - |
| Proxy statement | DEF 14A | 2025-04-15 | 2025-06-04 |
| Insider trade | 4 | 2025-04-02 | 2025-04-01 |
| Insider trade | 4 | 2025-03-21 | 2025-03-19 |
| Insider sale notice | 144 | 2025-03-19 | - |
| Annual report | 10-K | 2025-03-18 | 2024-12-31 |
| Insider trade | 4 | 2025-03-10 | 2025-03-06 |
| Insider trade | 4 | 2025-03-10 | 2025-03-06 |
| NT 10-K | - | 2025-03-03 | 2024-12-31 |
| Major company event | 8-K | 2025-03-03 | 2025-03-03 |
| Insider trade | 4 | 2025-02-27 | 2025-02-25 |
| Insider trade | 4 | 2025-02-27 | 2025-02-25 |
| Insider trade | 4 | 2025-02-27 | 2025-02-26 |
| Insider trade | 4 | 2025-02-21 | 2025-02-19 |
| Insider trade | 4 | 2025-02-21 | 2025-02-19 |
| Insider trade | 4 | 2025-02-21 | 2025-02-19 |
| Insider trade | 4 | 2025-02-21 | 2025-02-19 |